ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

ABVC ABVC BioPharma Inc

0,7333
0,00 (0,00%)
Pré-mercado
Última atualização: 05:00:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
ABVC BioPharma Inc ABVC NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 0,7333 05:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,7333
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/04/202410:25GLOBEAiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
17/04/202410:00GLOBEABVC BioPharma Executes a Global Licensing Definitive..
10/04/202409:30GLOBEABVC BioPharma Executes a Global Licensing Term Sheet for..
26/03/202409:30GLOBEABVC BioPharma Entered into a Global Licensing Deal of..
21/03/202409:30GLOBEAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
19/03/202409:30GLOBEABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
14/03/202410:30GLOBEABVC BioPharma Reports Annual 2023 Financials and Provides..
27/02/202410:30GLOBEABVC's New Horizon for Oncology and Hematology Aims at..
15/02/202410:30GLOBEABVC BioPharma Executes a Definitive Agreement to Receive..
12/02/202410:30GLOBEABVC BioPharma Receives Australian Patent, Valid Until 2040,..
08/02/202411:17GLOBEABVC Acquires $2.96 Million Worth of Land in Asia with..
03/01/202409:24GLOBEABVC BioPharma and its Subsidiary Receive $460M From AiBtl..
07/12/202310:30GLOBEABVC BioPharma Announces Completion of Subject Treatment for..
05/12/202310:30GLOBEABVC BioPharma Shares Insights from Dr. Scott Irwin of..
21/11/202310:30GLOBEABVC BioPharma Receives U.S. Patent for ADHD Treatment, a..
16/11/202312:05GLOBEABVC BioPharma Enters Definitive Agreement with Licensing..
15/11/202311:00GLOBEABVC BioPharma Reports Third Quarter 2023 Financial and..
26/10/202309:30GLOBEABVC BioPharma Entered Into a Term Sheet to License Global..
17/10/202309:30GLOBEABVC BioPharma Announces Completion of Subject Recruitment..
09/10/202309:30GLOBEABVC BioPharma Receives Taiwanese Patent for Its Treatment..
23/08/202309:30GLOBEABVC BioPharma Provides Updates on ADHD Phase IIb Clinical..
17/08/202310:19GLOBEABVC Executes Cooperation Agreement for Strategic..
10/08/202309:30GLOBEABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid..
07/08/202309:30GLOBEABVC Corporate Update and CEO's Letter to Shareholders
03/08/202310:20GLOBEABVC Announces the Approval of the Plan for GMP Production..
01/08/202309:30GLOBEABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M..
31/07/202310:30GLOBEABVC BioPharma Announces Closing on $1.75 Million Registered..
27/07/202310:22GLOBEABVC BioPharma Announces Pricing of $1.75 Million Registered..
26/07/202311:25APSBiotech Stock Soars On Strategic Investment Announcement
26/07/202309:30GLOBEABVC Signs Term Sheet to Acquire Real Estate Assets for..
24/07/202313:30GLOBEABVC BioPharma Announces Reverse Stock Split
06/07/202309:30GLOBEThe New CEO of ABVC BioPharma Takes Steps to Help Improve..

Seu Histórico Recente

Delayed Upgrade Clock